Israel’s Chief Scientist has awarded biotech Cell Cure Neurosciences a $1.5 million grant to help develop their cell-based OpRegen treatment for macular degeneration. The dry form of age-related macular degeneration is estimated to afflict over 7.3 million people in the US alone.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000844426&fid=1725